Breakout Stocks of Week 10
NASDAQ was down last week (week 9) by -1.17% ending at 16,085.11 points after falling -189.83 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Harpoon Therapeutics Inc. NASDAQ:HARP. This stock has had a buy signal since Jan 09, 2024 when the price was $22.36 and is so far up 2.91% to $23.01. Some other companies are on our watchlist to, among these are PGT NASDAQ:PGTI PC Connection Inc NASDAQ:CNXN Novartis AG NYSE:NVS and NMI Holdings Inc NASDAQ:NMIH which all got a breakout pattern emerging.
| Date | Company | Price | Week 10 |
|---|---|---|---|
| Harpoon Therapeutics Inc. | $23.01 | $23.01 | 0% |
| Pgt | $41.84 | $41.84 | 0% |
| Pc Connection Inc | $65.48 | $64.33 | -1.76% |
| Novartis Ag | $100.71 | $97.27 | -3.42% |
| Nmi Holdings Inc | $29.27 | $30.01 | 2.53% |
The Harpoon Therapeutics Inc. stock price gained 0.0870% on the last trading day (Friday, 8th Mar 2024), rising from $22.99 to $23.01. During the last trading day the stock fluctuated 0.130% from a day low at $22.99 to a day high of $23.02. The price has risen in 6 of the last 10 days and is up by 0.35% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $147.30 million.
On Dec 14, 2022, it was reported that Goldman Sachs gave HARP a "Sell" grade with a "initialise" action.
Harpoon Therapeutics Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Harpoon Therapeutics Inc.:
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
The PGT stock price gained 0.0478% on the last trading day (Friday, 8th Mar 2024), rising from $41.82 to $41.84. During the last trading day the stock fluctuated 0.191% from a day low at $41.83 to a day high of $41.91. The price has risen in 5 of the last 10 days and is up by 0.12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 91 thousand more shares were traded than the day before. In total, 898 thousand shares were bought and sold for approximately $37.58 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for PGT stock to perform well in the short-term.
About PGT:
PGT Innovations, Inc., together with its subsidiaries manufactures and supplies impact-resistant aluminum frame windows and doors in the United States and internationally. The company provides heavy-duty aluminum or vinyl frames with laminated glass to provide protection from hurricane-force winds and wind-borne debris; and non-impact resistant vinyl windows with insulating glass and multi-chambered frames for various climate zones. It also offers customizable non-impact-resistant aluminum frame windows and doors; and non-glass vertical and horizontal sliding panels for porch enclosures, including vinyl-glazed aluminum-framed products used for enclosing screened-in porches that provide protection from inclement weather. In addition, the company provides premium aluminum impact-resistant products; aluminum impact-resistant windows and doors; vinyl energy-efficient impact-resistant windows; and commercial storefront window system and entry doors. Further, it provides impact and non-impact sliding glass and terrace doors; fixed picture, single hung, and horizontal rolling windows; aluminum thermally broken doors and windows; fixed and operating windows; sliding, folding, and hinged doors; and moving glass walls and windows. The company offers its products under the PGT, CGI, WinDoor, Western Window Systems, NewSouth, Eco Window Systems, and Anlin brands. It serves window distributors, building supply distributors, window replacement dealers, and enclosure contractors. The company was formerly known as PGT, Inc. and changed its name to PGT Innovations, Inc. in December 2016. PGT Innovations, Inc. was founded in 1980 and is headquartered in North Venice, Florida.
The PC Connection Inc stock price gained 0.107% on the last trading day (Friday, 8th Mar 2024), rising from $65.41 to $65.48. During the last trading day the stock fluctuated 1.58% from a day low at $65.18 to a day high of $66.21. The price has fallen in 6 of the last 10 days and is down by -3.96% for this period. Volume fell on the last day by -13 thousand shares and in total, 50 thousand shares were bought and sold for approximately $3.30 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About PC Connection Inc:
PC Connection, Inc., together with its subsidiaries, provides various information technology (IT) solutions. The company operates through three segments: Business Solutions, Enterprise Solutions, and Public Sector Solutions. It offers IT products, including computer systems, data center solutions, software and peripheral equipment, networking communications, and other products and accessories, as well as provides services related to design, configuration, and implementation of IT solutions. The company markets its products and services through its websites comprising connection.com, connection.com/enterprise, connection.com/publicsector, and macconnection.com. It serves small to medium-sized businesses (SMBs) that include small office/home office customers; government and educational institutions; and medium-to-large corporate accounts through outbound telemarketing and field sales, and marketing programs targeted to specific customer populations, as well as through digital, web, and print media advertising. The company was founded in 1982 and is headquartered in Merrimack, New Hampshire.
The Novartis AG stock price gained 0.781% on the last trading day (Friday, 8th Mar 2024), rising from $99.93 to $100.71. During the last trading day the stock fluctuated 0.88% from a day low at $99.99 to a day high of $100.87. The price has fallen in 6 of the last 10 days and is down by -3.07% for this period. Volume fell on the last day by -626 thousand shares and in total, 830 thousand shares were bought and sold for approximately $83.56 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
On Apr 24, 2024, it was reported that UBS gave NVS a "Buy" grade with a "hold" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Novartis AG:
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
The NMI Holdings Inc stock price fell by -0.102% on the last day (Friday, 8th Mar 2024) from $29.30 to $29.27. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.92% from a day low at $29.24 to a day high of $29.80. The price has fallen in 7 of the last 10 days and is down by -1.01% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 332 thousand shares were bought and sold for approximately $9.71 million.
On Feb 15, 2024, it was reported that RBC Capital gave NMIH a "Sector Perform" grade with a "hold" action.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for NMI Holdings Inc stock to perform well in the short-term period.
About NMI Holdings Inc:
NMI Holdings, Inc. provides private mortgage guaranty insurance services in the United States. The company offers mortgage insurance services; and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, internet-sourced lenders, and other non-bank lenders. NMI Holdings, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
